When does the sparsentan patent expire?
I can’t determine a specific “sparsentan patent expiry” date from the information provided. Patent expiry depends on the exact country and on which right is being considered (for example, primary patent vs. additional protection such as pediatric extensions, supplemental protection certificates, or other jurisdiction-specific exclusivities).
Which patents control sparsentan exclusivity (and which one matters for “expiry”)?
“Patent expiry” can refer to different layers of protection:
- the end of the main compound/formulation patent term,
- the end of any method-of-use or additional patents that block specific claims,
- extensions that can legally extend market protection in some jurisdictions,
- regulatory exclusivities (which are separate from patents).
To answer precisely, we need either:
- the patent numbers/patent family for sparsentan you care about, or
- the jurisdiction(s) (e.g., US, EU, UK, Japan, Canada) and the product/indication.
Does sparsentan have exclusivity beyond the patent term (data exclusivity or regulatory exclusivity)?
Even after patent expiry, products can remain protected by non-patent exclusivities tied to regulatory approval. Whether that applies to sparsentan depends on the approval history in the relevant region and the specific exclusivity type (data protection vs. marketing/remaining exclusivity).
How long can protection last in the EU vs the US?
Patent term rules and any extension mechanisms differ by jurisdiction. The “expiry” date you see in one country may not match another because:
- extension options vary (e.g., EU SPC rules),
- regulatory exclusivity timelines differ,
- courts can stay or limit generic/biosimilar entry based on litigation.
What happens if a generic/applicant challenges the sparsentan patents?
If a challenger targets sparsentan patents, outcomes can include:
- early entry risk if key patents are invalid or non-infringing,
- delayed entry if patents survive,
- litigation-driven stays that postpone launch even when expiry is near.
This depends on the specific patents asserted and the procedural posture in each jurisdiction.
What I need to give you an exact expiry date
Reply with one of the following, and I’ll narrow to the correct expiry timeline:
1) the country/region (US, EU, UK, etc.) and whether you mean the main patent or “last protection,” or
2) the sparsentan patent number(s)/application number(s) you’re tracking, or
3) the trade name and indication (so we match the right patent set to the right claim scope).
Sources
No source material was provided with the question, so I can’t cite any specific sparsentan patent/expiry information.